SHREVEPORT, La. - In 2011, Shane Sumlin's life changed overnight after being diagnosed with a rare neurological disorder ...

The primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with tanruprubart at a dose of 30 mg/kg recovered to a healthy state with a score of 0 or ...

As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...

Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced its interim report for January-March 2025.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A week later, Abraham woke up in the middle of the night and tried to stand. She collapsed to the floor, struggling to ...

This announcement was made alongside the reveal of positive Phase 3 results for Tanruprubart, a monoclonal antibody that can block C1q and can potentially halt neuroinflammation and nerve damage in ...

Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...

Freddie Freeman's wife Chelsea is giving a positive update on her 4-year-old son Max after he was hospitalized over the ...

A weakened gut equates to an overworked immune system, boosting the chances of conditions such as GBS.” Guillain-Barré Syndrome: The Frightening Illness Linked to Your Favourite Foods.( ...